Deutsche Bank analyst Emmanuel Papadakis raised the firm’s price target on Novo Nordisk to DKK 950 from DKK 850 and keeps a Hold rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NVO:
- New Environmental / Social Risk for Novo Nordisk – What’s the Latest?
- Unusually active option classes on open January 31st
- Novo Nordisk sees 2024 sales growth of 18-26% at CER
- Novo Nordisk reports 2023 sales up 36% at constant exchange rates to DKK 232.3B
- Novo Nordisk (NYSE:NVO) Reaches New High on Robust Q4 Performance